Institutional investors purchased a net $4.3 million shares of MNOV during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 19.13% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 8.0 Thousand shares of MediciNova Inc
THE VANGUARD GROUP, INC. Bought 3.9 Thousand shares of MediciNova Inc
FNY CAPITAL MANAGEMENT LP Sold 25.2 Thousand shares of MediciNova Inc